NGF-induced neurite outgrowth of PC12 cells in the presence of phosphatidylcholine hydroperoxides: Implication for ageing

Mechanisms of Ageing and Development

Volumn 129, Issue 4, 2008, Pages 215-222

  Yamanaka, Yukako ^a   Yoshida, Shumi ^a   Doi, Hiroshi ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Membrane lipid; Microtubule; Oxidative stress; Phosphatidylcholine hydroperoxide; Tubulin

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LIPID HYDROPEROXIDE; NERVE GROWTH FACTOR; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; TUBULIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL LOSS; CELL MEMBRANE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; LIPID PEROXIDATION; MICROTUBULE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 39749097761     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.12.008     Document Type: Article

References (58)

1. P.J. Anderson The structure and amount of tubulin in cells and tissues J. Biol. Chem. 254 1979 2168 2171
2. S. Arlt U. Beisiegel A. Kontush Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease Curr. Opin. Lipidol. 13 2002 289 294
3. G. Barja Free radicals and aging Trends Neurosci. 27 2004 595 600
4. K.J. Barnham C.L. Masters A.I. Bush Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 3 2004 205 214
5. R. Brandt Cytoskeletal mechanisms of neuronal degeneration Cell Tissue Res. 305 2001 255 265
6. D.A. Butterfield J. Drake C. Pocernich A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol. Med. 7 2001 548 554
7. D.A. Butterfield T. Reed M. Perluigi C. De Marco R. Coccia C. Cini R. Sultana Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci. Lett. 397 2006 170 173
8. S. Camandola G. Poli M.P. Mattson The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons J. Neurochem. 74 2000 159 168
9. Y. Cheng M. Chen M. James-Kracke P. Wixom A.Y. Sun Enhanced lipid peroxidation by extracellular ATP in PC12 cells Neurochem. Res. 21 1996 27 33
10. C.C. Curtain F. Ali I. Volitakis R.A. Cherny R.S. Norton K. Beyreuther C.J. Barrow C.L. Masters A.I. Bush K.J. Barnham Alzheimer's disease amyloid-beta binds copper and zinc to generate anallosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits J. Biol. Chem. 276 2001 20466 20473
11. T. David-Pfeuty H.P. Erickson D. Pantaloni Guanosinetriphosphatase activity of tubulin associated with microtubuleassembly Proc. Natl. Acad. Sci. USA 74 1977 5372 5376
12. Miranda M. DiCiero V.M. de Bruin M.R. Vale G.S. Viana Lipid peroxidation and nitrite plus nitrate levels in brain tissue frompatients with Alzheimer's disease Gerontology 46 2000 179 184
13. H. Doi T. Imanishi K. Iwami F. Ibuki Is microtubule assembly not associated with GTP hydrolysis? Agric. Biol. Chem. 55 1991 245 246
14. L.A. Greene A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytomacells which respond to nerve growth factor Proc. Natl. Acad. Sci. USA 73 1976 2424 2428
15. D. Hedley S. Chow Flow cytometric measurement of lipid peroxidation in vital cells using parinaric acid Cytometry 13 1992 686 692
16. B. Hempen J.P. Brion Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease J. Neuropathol. Exp. Neurol. 55 1996 964 972
17. G. Hiller K. Weber Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues Cell 14 1978 795 804
18. D.B. Hinshaw M.T. Miller G.M. Omann T.F. Beals P.A. Hyslop A cellular model of oxidant-mediated neuronal injury Brain Res. 615 1993 13 26
19. X. Huang M.P. Cuajungco C.S. Atwood M.A. Hartshorn J.D. Tyndall G.R. Hanson K.C. Stokes M. Leopold G. Multhaup L.E. Goldstein R.C. Scarpa A.J. Saunders J. Lim R.D. Moir C. Glabe E.F. Bowden C.L. Masters D.P. Fairlie R.E. Tanzi A.I. Bush Cu(II) potentiation of alzheimer abeta neurotoxicity Correlation with cell-free hydrogen peroxide production and metal reduction J. Biol. Chem. 274 1999 37111 37116
20. X. Huang C.S. Atwood M.A. Hartshorn G. Multhaup L.E. Goldstein R.C. Scarpa M.P. Cuajungco D.N. Gray J. Lim R.D. Moir R.E. Tanzi A.I. Bush The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction Biochemistry 38 1999 7609 7616
21. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S26 S38
22. M. Kawakami K. Kanazawa H. Doi Effects of lecithin peroxides on microtubule assembly of tubulin J. Jpn. Soc. Nutr. Food Sci. 46 1993 89 91
23. M. Kawakami K. Hasegawa H. Doi Effect of phospholipids peroxides on GTPase activity of tubulin Bull. Mukogawa Women's Univ. Nat. Sci. 42 1994 17 23
24. M. Kawakami L. Ward H. Doi Inhibition of tubulin guanosine-5′-triphosphatase by lipid peroxides: protective effects of vitamin A derivatives J. Am. Oil Chem. Soc. 75 1998 635 641
25. M. Kawakami L. Ward H. Doi Mechanisms of tubulin modification by phosphatidylcholine hydroperoxides Lipids 35 2000 205 211
26. N.P. Kedar Can we prevent Parkinson's and Alzheimer's disease? J. Postgrad. Med. 49 2003 236 245
27. C.H. Keith Neurite elongation is blocked if microtubule polymerization is inhibited in PC12 cells Cell Motil. Cytoskeleton 17 1990 95 105
28. J.N. Keller M.P. Mattson Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system Rev. Neurosci. 9 1998 105 116
29. M. Kinoshita S. Oikawa K. Hayasaka A. Sekikawa T. Nagashima T. Toyota T. Miyazawa Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia Clin. Chem. 46 2000 822 828
30. P. Lamoureux V.L. Steel C. Regal L. Adgate R.E. Buxbaum S.R. Heidemann Extracellular matrix allows PC12 neurite elongation in the absence of microtubules J. Cell Biol. 110 1990 71 79
31. V.M. Lee Disruption of the cytoskeleton in Alzheimer's disease Curr. Opin. Neurobiol. 5 1995 663 668
32. E. Mariani M.C. Polidori A. Cherubini P. Mecocci Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 827 2005 65 75
33. W.R. Markesbery M.A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol. Aging 19 1998 33 36
34. W.R. Markesbery J.M. Carney Oxidative alterations in Alzheimer's disease Brain Pathol. 9 1999 133 146
35. W.R. Markesbery R.J. Kryscio M.A. Lovell J.D. Morrow Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment Ann. Neurol. 58 2005 730 735
36. J. Miquel A. Ramirez-Bosca A. Soler A. Diez M.A. Carrion-Gutierrez J. Diaz-Alperi E. Quintanilla-Ripoll A. Bernd E. Quintanilla-Almagro Increase with age of serum lipid peroxides: implications for the prevention of atherosclerosis Mech. Ageing Dev. 100 1998 17 24
37. S. Miranda C. Opazo L.F. Larrondo F.J. Munoz F. Ruiz F. Leighton N.C. Inestrosa The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease Prog. Neurobiol. 62 2000 633 648
38. T. Miyazawa T. Suzuki K. Fujimoto M. Kinoshita Age-related change of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide levels in normal human red blood cells Mech. Ageing Dev. 86 1996 145 150
39. T.J. Montine M.F. Beal M.E. Cudkowicz H. O’Donnell R.A. Margolin L. McFarland A.F. Bachrach W.E. Zackert L.J. Roberts J.D. Morrow Increased CSF F2-isoprostane concentration in probable AD Neurology 52 1999 562 565
40. T.J. Montine M.D. Neely J.F. Quinn M.F. Beal W.R. Markesbery L.J. Roberts J.D. Morrow Lipid peroxidation in aging brain and Alzheimer's disease Free Radic. Biol. Med. 33 2002 620 626
41. C. Napoli W. Palinski Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis Neurobiol. Aging 26 2005 293 302
42. M.D. Neely K.R. Sidell D.G. Graham T.J. Montine The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin J. Neurochem. 72 1999 2323 2333
43. J.S. O’Brien E.L. Sampson Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin J. Lipid Res. 6 1965 545 551
44. E.T. O’Brien W.A. Voter H.P. Erickson GTP hydrolysis during microtubule assembly Biochemistry 26 1987 4148 4156
45. W.A. Pedersen N.R. Cashman M.P. Mattson The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells Exp. Neurol. 155 1999 1 10
46. G. Perry A. Nunomura K. Hirai X. Zhu M. Perez J. Avila R.J. Castellani C.S. Atwood G. Aliev L.M. Sayre A. Takeda M.A. Smith Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33 2002 1475 1479
47. D. Pratico C.M. Clark F. Liun J. Rokach V.Y. Lee J.Q. Trojanowski Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease Arch. Neurol. 59 2002 972 976
48. D.L. Price R.J. Altschuler R.G. Struble M.F. Casanova L.C. Cork D.B. Murphy Sequestration of tubulin in neurons in Alzheimer's disease Brain Res. 385 1986 305 310
49. L.E. Rikans K.R. Hornbrook Lipid peroxidation, antioxidant protection and aging Biochim. Biophys. Acta 1362 1997 116 127
50. L.M. Sayre M.A. Smith G. Perry Chemistry and biochemistry of oxidative stress in neurodegenerative disease Curr. Med. Chem. 8 2001 721 738
51. S.W. Scheff S.T. DeKosky D.A. Price Quantitative assessment of cortical synaptic density in Alzheimer's disease Neurobiol. Aging 11 1990 29 37
52. R. Seckler G.M. Wu S.N. Timasheff Interactions of tubulin with guanylyl-(beta-gamma-methylene)diphosphonate Formation and assembly of a stoichiometric complex J. Biol. Chem. 265 1990 7655 7661
53. E.R. Skinner C. Watt J.A. Besson P.V. Best Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects Brain 116 1993 717 725
54. G. Spiteller Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products Free Radic. Biol. Med. 41 2006 362 387
55. B.J. Tabner O.M. El-Agnaf S. Turnbull M.J. German K.E. Paleologou Y. Hayashi L.J. Cooper N.J. Fullwood D. Allsop Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia J. Biol. Chem. 280 2005 35789 35792
56. R.D. Terry E. Masliah D.P. Salmon N. Butters R. DeTeresa R. Hill L.A. Hansen R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
57. T.I. Williams B.C. Lynn W.R. Markesbery M.A. Lovell Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease Neurobiol. Aging 27 2006 1094 1099
58. D. Yin K. Chen The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions Exp. Gerontol. 40 2005 455 465